XML 69 R37.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule Of Share Based Compensation Shares Authorized Under Stock Plans Issued And Avaliability
(in thousands)
Common stock authorized19,000 
Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled awards(8,589)
Common stock available for grant of stock-based awards as of December 31, 202410,411 
In addition, vested and unvested options to purchase 31 shares of common stock and 133 shares of unvested restricted stock awarded under the 2006 Plan were outstanding as of December 31, 2024.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
The following weighted average assumptions were used for stock options granted during 2024, 2023, and 2022:
Years Ended December 31,
202420232022
Volatility
34.1% to 47.4%
37.3% to 48.1%
42.5% to 51.1%
Risk free interest rate
4.0% to 4.6%
3.7% to 4.7%
1.2% to 3.0%
Expected life in years
3.0 to 4.0
3.0 to 5.0
3.0 to 5.0
Dividend yield2.0%2.5%2.1%
Weighted average fair value$13.22$10.12$13.42
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
For the years ended December 31, 2024, 2023, and 2022, the total equity-based compensation costs were as follows:
Years Ended December 31,
(in thousands)202420232022
Restricted stock awards$22,281 $21,301 $20,755 
Stock options2,459 2,597 3,391 
Performance-based awards1,799 250 250 
Total$26,539 $24,148 $24,396 
Schedule of cash proceeds and intrinsic values for stock options exercised table text block
Stock Options
Activity relating to stock options granted under the Company’s plans during the year ended December 31, 2023 and 2024 was as follows:
(in thousands except per share data)Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at January 1, 20232,766 $29.82 
Granted237 30.74 
Exercised(1,654)25.14 
Expired(229)36.01 
Forfeited(2)46.28 
Outstanding at December 31, 20231,118 $35.62 3.2 years$7,684 
Vested and Exercisable at December 31, 2023935 $35.91 3.0 years$6,167 
Outstanding at January 1, 20241,118 35.62 
Granted233 41.32 
Exercised(73)32.76 
Expired(2)46.47 
Forfeited(8)34.54 
Outstanding at December 31, 20241,268 $36.82 2.7 years$7,611 
Vested and Exercisable at December 31, 20241,116 $36.24 2.4 years$7,371 
As of December 31, 2024, $1,326 of total unrecognized compensation cost related to non-vested stock option awards is expected to be recognized on a straight-line basis over a weighted-average period of 0.9 years.
Additional information pertaining to the Company's stock option plan was as follows:
Years Ended December 31,
(in thousands except per share data)202420232022
Weighted-average grant date fair value of awards granted$41.32 $30.74 $36.95 
Cash received from the exercise of stock options$1,613 $1,205 $602 
Intrinsic value of stock options exercised$791 $16,335 $314 
Tax benefits realized on exercise of stock options$39 $1,285 $41